welbournes

The Department of Health and Social Care (DHSC) has today (20/01/2023) granted the following list of price concessions for January 2023.   Drug Pack Size Price concession Carbocisteine 250mg/5ml oral solution 300 £8.50 Cinnarizine 15mg tablets 84 £7.51 Clarithromycin 500mg tablets 14 £10.48 Co-amoxiclav 250mg/125mg tablets 21 £3.54 Colecalciferol 1,000unit capsules 30 £8.40 Erythromycin 250mg [...]

The post January 2023 Price Concessions 2nd Update appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (19/01/2023) granted the following initial list of price concessions for January 2023. Drug Pack Size Price concession Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.70 Amoxicillin 250mg/5ml oral suspension 100 [...]

The post January 2023 Price Concessions 1st Update appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Vigabatrin (Sabril®) 500mg tablets. MSN/2023/003 Tier 2 – medium impact Date of issue 17th January 2023 Vigabatrin (Sabril®) 500mg tablets are out of stock until w/c 3rd March 2023. An alternative formulation of the Sabril® brand of vigabatrin is the 500mg [...]

The post Medicine Supply Notification: Vigabatrin (Sabril® ) 500mg tablets appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for various Insuman insulin preparations. MSN/2023/002 Tier 2 – medium impact Date of issue 17th January 2023 Insuman® Comb 25 100units/ml suspension for injection 3ml cartridges and prefilled pens will be discontinued with stocks being exhausted in May and June 2023 respectively. [...]

The post Medicine Supply Notification: Various Insuman Insulin preparations appeared first on PSNC Website.

CLMR number: CLMR (23)A/01 Date issued: 12th January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection (Mawdsley-Brooks & Company Limited). Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine] Batch number Expiry Date Pack Size First Distributed 200686 [...]

The post Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited appeared first on PSNC Website.